Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism

INTRODUCTION: A patient-reported outcome (PRO) measure specific to chronic hypoparathyroidism is lacking to facilitate the evaluation of treatment. A PRO measure that followed the recommendations of the US Food and Drug Administration (FDA) PRO guidance was created to address key hypoparathyroidism...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Susan, Chen, Kristina, Harris, Nimanee, Vera-Llonch, Montserrat, Krasner, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822864/
https://www.ncbi.nlm.nih.gov/pubmed/31183782
http://dx.doi.org/10.1007/s12325-019-00999-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822864/
https://www.ncbi.nlm.nih.gov/pubmed/31183782
http://dx.doi.org/10.1007/s12325-019-00999-2

Ejemplares similares